Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXX37K
|
||||
Drug Name |
N-[1-(2S-Ethyl-4-oxo-tetrahydro-furan-3S-ylcarbamoyl)-2S-(1-methyl-cyclopentyl)-ethyl]-4-(toluene-2-sulfonylamino)-benzamide
|
||||
Synonyms |
CHEMBL475063
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H37N3O6S
|
||||
Canonical SMILES |
CC[C@@H]1OCC(=O)[C@H]1NC(=O)[C@H](CC2(C)CCCC2)NC(=O)c3ccc(NS(=O)(=O)c4ccccc4C)cc3
|
||||
InChI |
InChI=1S/C29H37N3O6S/c1-4-24-26(23(33)18-38-24)31-28(35)22(17-29(3)15-7-8-16-29)30-27(34)20-11-13-21(14-12-20)32-39(36,37)25-10-6-5-9-19(25)2/h5-6,9-14,22,24,26,32H,4,7-8,15-18H2,1-3H3,(H,30,34)(H,31,35)/t22-,24-,26+/m0/s1
|
||||
InChIKey |
QIZMDQBBKHFWJF-LLZJGCNPSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.